Shahzad Malik's Net Worth
$172 Thousand
Who is Shahzad Malik?
Shahzad Malik does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Axonics Modulation Technologies, Inc., AGENUS INC, Emergent BioSolutions Inc., Acutus Medical, Inc., Iterum Therapeutics plc, Conatus Pharmaceuticals Inc, and Versartis, Inc..
SEC CIK
Shahzad Malik's CIK is 0001380178
Past Insider Trading and Trends
2019 was Shahzad Malik's most active year for acquiring shares with 4 total transactions. Shahzad Malik's most active month to acquire stocks was the month of May. 2015 saw Shahzad Malik paying a total of $158,062.50 for 36,425 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Axonics Modulation Technologies, Inc. (AXNX) Snapshot price: $68.7655
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.5K |
—
|
—
| 2.5K |
Dec 6
| |||
Form 4
| +64.96% | 1.69M |
—
|
—
| 4.3M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AGENUS INC (AGEN) Snapshot price: $4.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
∞
| 1.59M |
$6.30 | $10,000,002.60 | 1.59M |
May 27
| |||
Form 4
| -100.00% | -1.00M |
$5.06 | -$7,537,613.13 |
0
|
May 8 - Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Emergent BioSolutions Inc. (EBS) Snapshot price: $7.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Acutus Medical, Inc. (AFIB) Snapshot price: $0.0315
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +81.01% | 1.8K |
—
|
—
| 4.02K |
Jun 17
| |||
Form 4
|
∞
| 1.62M |
—
|
—
| 1.62M |
Aug 10
| |||
Form 4
|
∞
| 2.22K |
—
|
—
| 2.22K |
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Iterum Therapeutics plc (ITRM) Snapshot price: $1.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
∞
| 868.16K |
$13.00 |
—
| 868.16K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |